The FDA has expanded the approval of Baqsimi nasal powder to include treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

Medically reviewed by Suzanne Fisher, RD Hypoglycemia (low blood sugar) treatments will depend on the severity of symptoms ...

Inhalation (nebulized or aerosolized) is the only known method that increases GSH's levels in the ELF. A review of the literature was conducted to examine the clinical effectiveness of inhaled GSH ...

of crystalline glucagon. ¶ The patients' symptoms and their response to glucagon were recorded. Data on the effect of glucagon in 27 spontaneous insulin reactions occurring in 11 of the 18 ...

By inhibiting DPP4, vildagliptin causes an increase in glucagon like peptide-1 (GLP-1 ... With the exception of inhaled insulin, none of the other recently approved diabetes medications are ...